Stifel Jaws & Paws Conference 2026
Logotype for Henry Schein Inc

Henry Schein (HSIC) Stifel Jaws & Paws Conference 2026 summary

Event summary combining transcript, slides, and related documents.

Logotype for Henry Schein Inc

Stifel Jaws & Paws Conference 2026 summary

27 May, 2026

Strategic priorities and business transformation

  • Leadership is focused on delivering on 2026 guidance and value creation initiatives, with progress on both fronts.

  • Efforts are underway to simplify the business, reduce silos, and better align commercial approaches to enhance customer partnerships.

  • Growth is being driven by scaling technology and own brands, with a focus on market share gains in distribution.

  • Accelerated innovation is expected through internal AI development and industry partnerships, especially in technology and specialty products.

  • Value creation initiatives target $125 million run rate by year-end and up to $200 million over the next few years, emphasizing both gross profit and cost efficiencies.

Market trends and business performance

  • Dental market remains steady, largely insulated from consumer confidence swings, and is more sensitive to employment rates.

  • Dental business momentum has continued from Q1 into May, with share gains attributed to promotional activity and experienced sales hires.

  • Medical segment faced Q1 headwinds from diagnostic test kits, but underlying business showed mid-single-digit growth, expected to continue.

  • Internationally, Germany and Canada are highlighted as strong performers, with Canada effectively managing competitive challenges.

  • Internal revenue growth of 2.5% in Q1 is seen as a trough, with expectations for improvement as headwinds subside.

Product innovation and portfolio development

  • New product launches are accelerating, with a focus on both supplier-driven and internally developed offerings, such as the exclusive Curodont launch.

  • AI-driven capabilities and cloud-based platforms are being prioritized to increase recurring revenue and customer value.

  • Specialty products, particularly implants, are a growth focus, with recent majority ownership in a value implant business expected to drive expansion.

  • Distribution, specialty, and technology businesses are all positioned for above-market growth through expanded offerings and value-added services.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more